Full Value Poultry logo
Agita logo
Coban logo
Maxiban logo
Monteban logo
Hemicell logo
Surmax logo
Clinacox logo
AviPro logo

Maxiban logo

A potentiated ionophore that prevents coccidiosis and protects intestinal integrity

Maxiban is a potentiated ionophore that combines the strength of an ionophore, and a chemical to prevent coccidiosis throughout a birds life1. This powerful combination creates:

  • A synergistic mode of action from the 1:1 mixture of narasin (ionophore) and nicarbazin (chemical)
  • Enhanced capabilities to maximize coccidiosis control and maintain intestinal integrity

Each component of Maxiban® is active during different stages of the coccidia life cycle.3 This two-stage mechanism produces a greater response than single-agent medications.

Preventing coccidiosis to help improve performance and help protect Intestinal Integrity

By preventing coccidiosis, Maxiban®:

  • Provides improved weight gain4
  • Provides improved feed conversion5
  • Helps protect intestinal integrity.

    As a result, the bird’s body can direct nutrients toward growth rather than fighting diseases. This helps power birds through the critical stages when they face the greatest coccidiosis challenge.

Important Safety Information

The label contains complete use information, including cautions and warning. Always read, understand and follow the label and use directions.

  1. Dykstra, D. and Reid, W. 1978. “Monensin, Eimeria tenella infection and effects on the bacterial population of gnotobiotic chickens.” Poultry Sci. 57.

  2. Brennan, J. Bagg, R. et al. 2001. “Efficacy of narasin the prevention of necrotic enteritis in broiler chickens.” Avian Diseases. 45.

  3. Bafundo, K. and Jeffers, T. Sept. 1990. “Selection for resistance to monensin, nicarbazin and the monensin plus nicarbazin combination.” Poultry Sci.

  4. Watkins, K. and Bafundo, K. Spring 1993. “Effect of anticoccidial programs on broiler performance.” Journ. Applied Poultry Research. Spring.

  5. Rings, B. Cochrane, J. et al. July 2001. “The performance of Maxiban and nicarbazin with and without BMD in starter rations.” AVMA Presentation, Boston, Mass.